<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(6)</volume><submitter>Duan T</submitter><pubmed_abstract>Though alprostadil has been reported to improve the impaired microcirculation of patients with pulmonary arterial hypertension, its effectiveness as a treatment for coronary microvasculature dysfunction (CMD) following ST-segment elevation myocardial infarction (STEMI) is unknown. A total of 18 miniature pigs with CMD following STEMI were randomized into three groups that received an intracoronary injection of 5 ml of normal saline, 2 mg of nicorandil or 10 µg of alprostadil immediately after measurement of the index of microcirculatory resistance (IMR) and then an intravenous drip containing 5 ml of normal saline, 2 mg of nicorandil or 10 µg of alprostadil once a day for 6 days. The IMR, cardiac function using ultrasound, infarct areas and heparanase levels in infarct areas were measured </pubmed_abstract><journal>Experimental and therapeutic medicine</journal><pagination>1449</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8549090</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The effectiveness of alprostadil in treating coronary microcirculation dysfunction following ST-segment elevation myocardial infarction in a pig model.</pubmed_title><pmcid>PMC8549090</pmcid><pubmed_authors>Kong R</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Song R</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Xiang D</pubmed_authors><pubmed_authors>Duan T</pubmed_authors></additional><is_claimable>false</is_claimable><name>The effectiveness of alprostadil in treating coronary microcirculation dysfunction following ST-segment elevation myocardial infarction in a pig model.</name><description>Though alprostadil has been reported to improve the impaired microcirculation of patients with pulmonary arterial hypertension, its effectiveness as a treatment for coronary microvasculature dysfunction (CMD) following ST-segment elevation myocardial infarction (STEMI) is unknown. A total of 18 miniature pigs with CMD following STEMI were randomized into three groups that received an intracoronary injection of 5 ml of normal saline, 2 mg of nicorandil or 10 µg of alprostadil immediately after measurement of the index of microcirculatory resistance (IMR) and then an intravenous drip containing 5 ml of normal saline, 2 mg of nicorandil or 10 µg of alprostadil once a day for 6 days. The IMR, cardiac function using ultrasound, infarct areas and heparanase levels in infarct areas were measured </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-03T22:44:18.986Z</modification><creation>2022-02-11T12:18:52.494Z</creation></dates><accession>S-EPMC8549090</accession><cross_references><pubmed>34721691</pubmed><doi>10.3892/etm.2021.10884</doi></cross_references></HashMap>